Hikma Pharmaceuticals PLC Capital Reinvestment Ratio
Hikma Pharmaceuticals PLC capital reinvestment ratio. Hikma Pharmaceuticals PLC (HIK) has a Capital Reinvestment Ratio of 0.42x as of June 2025, meaning it reinvests 0% of its operating cash flow (GBX161.00 Million) in capital expenditures (GBX68.00 Million). See Hikma Pharmaceuticals PLC free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Hikma Pharmaceuticals PLC (2004–2024)
Capital reinvestment ratio of Hikma Pharmaceuticals PLC from 2004 to 2024. This chart tracks Hikma Pharmaceuticals PLC's Capital Reinvestment Ratio across 21 annual periods. See financial agility of Hikma Pharmaceuticals PLC to measure the company's free cash flow as a share of total liabilities.
Hikma Pharmaceuticals PLC Capital Reinvestment Ratio by Year (2004–2024)
Hikma Pharmaceuticals PLC capital reinvestment ratio by year from 2004 to 2024. For the full cash flow conversion analysis, see HIK cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.29x | GBX564.00 Million | GBX165.00 Million | ▲ +5.2% |
| 2023 | 0.28x | GBX608.00 Million | GBX169.00 Million | ▼ -34.5% |
| 2022 | 0.42x | GBX530.00 Million | GBX225.00 Million | ▲ +18.3% |
| 2021 | 0.36x | GBX638.00 Million | GBX229.00 Million | ▼ -25.6% |
| 2020 | 0.48x | GBX464.00 Million | GBX224.00 Million | ▲ +22.5% |
| 2019 | 0.39x | GBX472.00 Million | GBX186.00 Million | ▲ +58.4% |
| 2018 | 0.25x | GBX430.00 Million | GBX107.00 Million | ▲ +3.0% |
| 2017 | 0.24x | GBX443.00 Million | GBX107.00 Million | ▼ -42.0% |
| 2016 | 0.42x | GBX293.00 Million | GBX122.00 Million | ▲ +85.8% |
| 2015 | 0.22x | GBX366.00 Million | GBX82.00 Million | ▲ +4.6% |
| 2014 | 0.21x | GBX425.00 Million | GBX91.00 Million | ▲ +22.3% |
| 2013 | 0.18x | GBX337.00 Million | GBX59.00 Million | ▼ -64.6% |
| 2012 | 0.50x | GBX182.16 Million | GBX90.19 Million | ▼ -34.8% |
| 2011 | 0.76x | GBX102.64 Million | GBX78.00 Million | ▲ +98.3% |
| 2010 | 0.38x | GBX138.79 Million | GBX53.20 Million | ▲ +0.2% |
| 2009 | 0.38x | GBX105.52 Million | GBX40.38 Million | ▼ -66.2% |
| 2008 | 1.13x | GBX57.87 Million | GBX65.52 Million | ▼ -11.2% |
| 2007 | 1.28x | GBX43.12 Million | GBX54.99 Million | ▼ -27.1% |
| 2006 | 1.75x | GBX29.99 Million | GBX52.44 Million | ▲ +138.5% |
| 2005 | 0.73x | GBX32.71 Million | GBX23.98 Million | ▲ +12.9% |
| 2004 | 0.65x | GBX32.84 Million | GBX21.33 Million | — |